These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pharmacoepidemiology of niacin. Jungnickel PW; Maloley PA Ann Intern Med; 1995 Mar; 122(5):392-3. PubMed ID: 7847654 [No Abstract] [Full Text] [Related]
24. Cholestatic Drug-Induced Liver Injury in a Patient Taking High-Dose Niacin for Hyperlipidemia. Nawaz N; Mistretta T; Karime C; Lewis J; Wolf E J Investig Med High Impact Case Rep; 2024; 12():23247096231224349. PubMed ID: 38193433 [TBL] [Abstract][Full Text] [Related]
25. Safety and side effects of sustained-release niacin. Lavie CJ; Milani RV JAMA; 1994 Aug; 272(7):513-4; author reply 514-5. PubMed ID: 8046796 [No Abstract] [Full Text] [Related]
26. Safety considerations with niacin therapy. Guyton JR; Bays HE Am J Cardiol; 2007 Mar; 99(6A):22C-31C. PubMed ID: 17368274 [TBL] [Abstract][Full Text] [Related]
27. [Toxic and drug-induced hepatitis]. Murie Carrillo de Albornoz M; Uribarrena Echebarría R; Sánchez Alvarez J; Sauras Herranz MA; García Bragado F; Rivero Puente A Rev Clin Esp; 1988 Jul; 183(3):107-9. PubMed ID: 3187121 [No Abstract] [Full Text] [Related]
28. [Disulfiram-induced hepatitis]. Sundkvist T; Johansson B Lakartidningen; 1984 Dec; 81(51):4837. PubMed ID: 6521575 [No Abstract] [Full Text] [Related]